PURPOSE: To evaluate the association of the Hormad1 and Hormad2 single nucleotide polymorphisms (SNPs) variants with non-obstructive azoospermia (NOA) in the Chinese population. METHODS: In the present study, we assessed 10 single nucleotide polymorphisms (SNPs) of Hormad1 and Hormad2 using Sequenom iplex technology in 361 NOA cases and 368 normal controls from Chinese population. RESULTS: We observed no statistical differences in the distribution of allele frequencies. Further genetic model analysis and haplotype analysis also showed no significant difference between the two groups. However, we found that genotype distribution of rs718772 of Hormad2 was significantly different between the larger testis group (average testis volume ≥10 ml) and the small testis group (average testis volume <10 ml) in the NOA patients (P = 0.035). CONCLUSIONS: In conclusion, Hormad1 and Hormad2 might not be the susceptible genes for the non-obstructive azoospermia in our study population. However, rs718772 of Hormad2 variant might be associated with testis development in NOA patients.
PURPOSE: To evaluate the association of the Hormad1 and Hormad2 single nucleotide polymorphisms (SNPs) variants with non-obstructive azoospermia (NOA) in the Chinese population. METHODS: In the present study, we assessed 10 single nucleotide polymorphisms (SNPs) of Hormad1 and Hormad2 using Sequenom iplex technology in 361 NOA cases and 368 normal controls from Chinese population. RESULTS: We observed no statistical differences in the distribution of allele frequencies. Further genetic model analysis and haplotype analysis also showed no significant difference between the two groups. However, we found that genotype distribution of rs718772 of Hormad2 was significantly different between the larger testis group (average testis volume ≥10 ml) and the small testis group (average testis volume <10 ml) in the NOA patients (P = 0.035). CONCLUSIONS: In conclusion, Hormad1 and Hormad2 might not be the susceptible genes for the non-obstructive azoospermia in our study population. However, rs718772 of Hormad2 variant might be associated with testis development in NOA patients.
Authors: Michael Zitzmann; Verena Nordhoff; Victoria von Schönfeld; Annette Nordsiek-Mengede; Sabine Kliesch; Andreas N Schüring; Craig Marc Luetjens; Axel Kamischke; Trevor Cooper; Manuela Simoni; Eberhard Nieschlag Journal: Fertil Steril Date: 2006-06-06 Impact factor: 7.329
Authors: Yao-Tseng Chen; Charis A Venditti; Gregory Theiler; Brian J Stevenson; Christian Iseli; Ali O Gure; C Victor Jongeneel; Lloyd J Old; Andrew J G Simpson Journal: Cancer Immun Date: 2005-07-07
Authors: Stephen J Bromage; Debbie A Falconer; Brian A Lieberman; Vijay Sangar; Stephen R Payne Journal: Eur Urol Date: 2006-09-05 Impact factor: 20.096
Authors: Lukasz Wojtasz; Katrin Daniel; Ignasi Roig; Ewelina Bolcun-Filas; Huiling Xu; Verawan Boonsanay; Christian R Eckmann; Howard J Cooke; Maria Jasin; Scott Keeney; Michael J McKay; Attila Toth Journal: PLoS Genet Date: 2009-10-23 Impact factor: 5.917
Authors: Marco D'Aurora; Alberto Ferlin; Andrea Garolla; Sara Franchi; Laura D'Onofrio; Oriana Trubiani; Giandomenico Palka; Carlo Foresta; Liborio Stuppia; Valentina Gatta Journal: Sci Rep Date: 2017-03-31 Impact factor: 4.379